# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute Lymphoblastic Leukemia, Childhood

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 69 results.
Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)
Status: Recruiting
Last Changed: Jan 10, 2018
First Received: Jan 04, 2018
Disease(s): Childhood Acute Lymphoblastic Leukemia
Intervention(s): Dexamethasone continuous, Dexamethasone intermittent, Dexamethasone, Methylprednisolone, Daunorubicin, Idarubicin, Bortezomib, Second phase of induction, Standard induction therapy, Standard consolidation therapy
Locations: prof. R.O.Eolyan Hematology Center, Ereván, Armenia
Republican Research and Practical Center of Radiation Medicine and Human Ecology, Gomel, Belarus
Republic Research and Practical Center of Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
Mogilev Regional Children's Hospital, Mogilev, Belarus
National Oncology and Hematology Center, Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyzstan
... and 54 other locations.
A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects
Status: Recruiting
Last Changed: Dec 27, 2018
First Received: Aug 29, 2017
Disease(s): Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood, Relapsed/Refractory B-cell Lymphoma, Childhood
Intervention(s): BinD19
Locations: Children's Hospital of Fudan University, Shanghai, Shanghai, China
Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI
Status: Recruiting
Last Changed: Oct 10, 2018
First Received: Jun 15, 2017
Disease(s): Acute Lymphoblastic Leukemia
Intervention(s): Cognitive training
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
Status: Recruiting
Last Changed: Nov 14, 2018
First Received: Jun 04, 2018
Disease(s): Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence
Intervention(s): Mode of relapse detection
Locations: Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N, Denmark
Department of Paediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland
The National University Hospital of Iceland, Reykjavík, Iceland
Department of Childhood Oncology, University Hospital Tromsø, Tromsø, Norway
Department of Paediatric Oncology, Karolinska University Hospital, Stockholm, Sweden
... and 1 other locations.
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Status: Recruiting
Last Changed: Aug 01, 2018
First Received: Jan 13, 2017
Disease(s): Acute Lymphoblastic Leukemia, Pediatric
Intervention(s): Pegaspargase, Erwinia asparaginase, Cyclophosphamide, CYTARABINE, DASATINIB, DEXAMETHASONE, Dexrazoxane, Doxorubicin, ETOPOSIDE, HYDROCORTISONE, LEUCOVORIN CALCIUM, MERCAPTOPURINE, METHOTREXATE, NELARABINE, Vincristine
Locations: Boston Children's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Montefiore Medical Center, Bronx, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York, United States
... and 4 other locations.
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy
Status: Not yet recruiting
Last Changed: Mar 26, 2019
First Received: Mar 26, 2019
Disease(s): ALL, Childhood
Pharmacokinetics of Drugs Administered to Children
Status: Recruiting
Last Changed: Feb 26, 2019
First Received: Mar 29, 2018
Disease(s): Pediatric ALL
Intervention(s): Standard of care drug
Locations: Duke University, Durham, North Carolina, United States
Peds SM-THINk: Nursing Interventions to Improve Discharge Outcomes
Status: Recruiting
Last Changed: Oct 04, 2018
First Received: May 30, 2018
Disease(s): Pediatric ALL
Intervention(s): SM-THINk
Locations: Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: Jan 25, 2019
Disease(s): ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood
Intervention(s): Ixazomib, Vincristine, Dexamethasone, Asparaginase, Doxorubicin
Locations: Children's Hospital Los Angeles, Los Angeles, California, United States
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
Status: Not yet recruiting
Last Changed: Apr 02, 2019
First Received: Apr 02, 2019
Disease(s): Pediatric ALL
Intervention(s): ECG